Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
YS Biopharma to Participate in Citi's 18th Annual Biopharma Conference 2023-09-05 20:30
YS Biopharma Announces Purchase of Shares by Company Officers 2023-08-25 04:15
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024 2023-08-16 05:00
YS Biopharma to Report First Quarter Fiscal Year 2024 Financial Results on August 15, 2023 2023-08-11 04:30
YS Biopharma Announces Financial Results for Fiscal Year 2023 Ended March 31, 2023 2023-07-27 05:00
YS Biopharma to Report Financial Results for Fiscal Year 2023 on July 26, 2023 2023-07-22 04:30
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval From Philippines FDA 2023-06-01 20:30
YS Biopharma to Participate in the Virtual Benchmark Healthcare House Call Conference on May 23, 2023 2023-05-18 20:25
YS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical Trial Approval in Pakistan 2023-05-16 19:00
YS Biopharma Announces Record Vaccine Revenues and Preliminary Financial Results for FY2023 Ended March 31, 2023 2023-04-18 19:00
YS Biopharma's PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study 2023-03-27 18:00
1 2